Leica Biosystems Launches Joint Solution with Paige to Accelerate Adoption of Digital Pathology and AI

ORLANDO, FL – Leica Biosystems, a global leader in anatomic pathology, and Paige, a leader in digital pathology software and diagnostic AI applications, previously announced a partnership to create an integrated solution, to expand access to accelerate adoption of digital pathology and artificial intelligence (AI). The companies are now launching their integrated solution at the Digital Pathology Association’s (DPA) Pathology Visions 2023 conference in Orlando, Florida.

This launch will enable users of Leica Biosystems digital pathology scanners to experience Aperio Powered by Paige*, an all-in-one web-based solution that delivers a seamless implementation of Paige’s image management system and advanced whole-slide image viewer to help meet current needs including access to AI-driven support tools.

“AI is a new frontier for anatomic pathology, and we can’t access the full benefits of this technology without digital,” said Naveen Chandra, Vice President of Digital Pathology at Leica Biosystems. “Leica Biosystems partnering with Paige will empower pathologists to future-proof their workflows and aid in the fight against cancer.”

“We are thrilled to expand our collaboration with Leica Biosystems to further advance the transformation of cancer diagnostics in digital pathology and AI.” said Andy Moye, CEO at Paige. “Leica is a clear leader and innovator in this space, and pathologists will now be able to have a seamless interoperable workflow, from scanning, through case management, to viewing, and taking full advantage of the power of native AI.”

With a heritage of innovation spanning more than 150 years, Leica Biosystems has offered nine generations of continually improving digital slide scanning technology, realized in compact, user-friendly image capture devices that integrate with pathology workflows and laboratory information systems. Paige’s offerings include novel AI applications together with a powerful platform to easily view and manage whole slide images, putting the power of digital pathology into the hands of pathologists.

*At the time of writing, this solution is for research use only.

About Leica Biosystems:
Leica Biosystems is a cancer diagnostics company and a global leader in workflow solutions. The company offers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. As the only company to own the full workflow from biopsy to diagnosis, Leica Biosystems is uniquely positioned to break down the barriers between each step. The company’s mission of “Advancing Cancer Diagnostics, Improving Lives” is at the heart of its corporate culture.

About Paige
Paige uses the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.

Contact:
Lauren Meinhardt
Communications & Brand Director
LBS.GlobalMarketing@leicabiosystems.com